{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:30:53Z","timestamp":1779114653660,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Nouvelle Soci\u00e9t\u00e9 Fran\u00e7aise d'Ath\u00e9roscl\u00e9rose"},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00056850"],"award-info":[{"award-number":["00056850"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CE14-0009-01"],"award-info":[{"award-number":["ANR-16-CE14-0009-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20170336737"],"award-info":[{"award-number":["DEQ20170336737"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2021,6,4]]},"DOI":"10.15252\/embr.202051299","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:43:38Z","timestamp":1619034218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["PI3KC2\u03b2 inactivation stabilizes VE-cadherin junctions and preserves vascular integrity"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-7854","authenticated-orcid":false,"given":"Typhaine","family":"Anquetil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Solinhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Jaffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Chicanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-5642","authenticated-orcid":false,"given":"Julien","family":"Viaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Darcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Orset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-2186","authenticated-orcid":false,"given":"Eva","family":"Geuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7074-3673","authenticated-orcid":false,"given":"Bart","family":"Vanhaesebroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Vivien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Hnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Larrue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Payrastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-6401","authenticated-orcid":false,"given":"Marie-Pierre","family":"Gratacap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"BFEMBR202051299_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","volume":"99","author":"EW Ades","year":"1992","unstructured":"Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683\u2013690","journal-title":"J Invest Dermatol"},{"key":"BFEMBR202051299_CR2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.celrep.2015.10.052","volume":"13","author":"S Alliouachene","year":"2015","unstructured":"Alliouachene S, Bilanges B, Chicanne G, Anderson KE, Pearce W, Ali K, Valet C, Posor Y, Low PC, Chaussade C et al (2015) Inactivation of the class II PI3K-C2beta potentiates insulin signaling and sensitivity. Cell Rep 13: 1881\u20131894","journal-title":"Cell Rep"},{"key":"BFEMBR202051299_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","volume":"17","author":"JB Bederson","year":"1986","unstructured":"Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472\u2013476","journal-title":"Stroke"},{"key":"BFEMBR202051299_CR4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","volume":"20","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev 20: 515\u2013534","journal-title":"Nat Rev"},{"key":"BFEMBR202051299_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-61779-307-3_3","volume":"788","author":"S Braeuninger","year":"2012","unstructured":"Braeuninger S, Kleinschnitz C, Nieswandt B, Stoll G (2012) Focal cerebral ischemia. Methods Mol Biol 788: 29\u201342","journal-title":"Methods Mol Biol"},{"key":"BFEMBR202051299_CR6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41589-018-0086-4","volume":"14","author":"CC Campa","year":"2018","unstructured":"Campa CC, Margaria JP, Derle A, Del Giudice M, De Santis MC, Gozzelino L, Copperi F, Bosia C, Hirsch E (2018) Rab11 activity and PtdIns(3)P turnover removes recycling cargo from endosomes. Nat Chem Biol 14: 801\u2013810","journal-title":"Nat Chem Biol"},{"key":"BFEMBR202051299_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1742-2094-8-162","volume":"8","author":"GV Chaitanya","year":"2011","unstructured":"Chaitanya GV, Cromer WE, Wells SR, Jennings MH, Couraud PO, Romero IA, Weksler B, Erdreich-Epstein A, Mathis JM, Minagar A et al (2011) Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro. J Neuroinflammation 8: 162","journal-title":"J Neuroinflammation"},{"key":"BFEMBR202051299_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/BJ20120945","volume":"447","author":"G Chicanne","year":"2012","unstructured":"Chicanne G, Severin S, Boscheron C, Terrisse AD, Gratacap MP, Gaits-Iacovoni F, Tronchere H, Payrastre B (2012) A novel mass assay to quantify the bioactive lipid PtdIns3P in various biological samples. Biochem J 447: 17\u201323","journal-title":"Biochem J"},{"key":"BFEMBR202051299_CR9","doi-asserted-by":"crossref","first-page":"18325","DOI":"10.18632\/oncotarget.7761","volume":"7","author":"A Chikh","year":"2016","unstructured":"Chikh A, Ferro R, Abbott JJ, Pineiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D, Ostano P, Chiorino G et al (2016) Class II phosphoinositide 3-kinase C2beta regulates a novel signaling pathway involved in breast cancer progression. Oncotarget 7: 18325\u201318345","journal-title":"Oncotarget"},{"key":"BFEMBR202051299_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneumeth.2012.10.001","volume":"212","author":"BP Daniels","year":"2013","unstructured":"Daniels BP, Cruz-Orengo L, Pasieka TJ, Couraud PO, Romero IA, Weksler B, Cooper JA, Doering TL, Klein RS (2013) Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods 212: 173\u2013179","journal-title":"J Neurosci Methods"},{"key":"BFEMBR202051299_CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-12-394311-8.00006-6","volume":"116","author":"E Dejana","year":"2013","unstructured":"Dejana E, Vestweber D (2013) The role of VE-cadherin in vascular morphogenesis and permeability control. Prog Mol Biol Transl Sci 116: 119\u2013144","journal-title":"Prog Mol Biol Transl Sci"},{"key":"BFEMBR202051299_CR12","first-page":"437","volume":"11","author":"C Esenwa","year":"2015","unstructured":"Esenwa C, Gutierrez J (2015) Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag 11: 437\u2013450","journal-title":"Vasc Health Risk Manag"},{"key":"BFEMBR202051299_CR13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/STROKEAHA.111.000544","volume":"44","author":"M Gauberti","year":"2013","unstructured":"Gauberti M, Montagne A, Marcos-Contreras OA, Le Behot A, Maubert E, Vivien D (2013) Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes. Stroke 44: 1988\u20131996","journal-title":"Stroke"},{"key":"BFEMBR202051299_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","volume":"26","author":"M Giannotta","year":"2013","unstructured":"Giannotta M, Trani M, Dejana E (2013) VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 26: 441\u2013454","journal-title":"Dev Cell"},{"key":"BFEMBR202051299_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tcb.2019.01.001","volume":"29","author":"F Gulluni","year":"2019","unstructured":"Gulluni F, De Santis MC, Margaria JP, Martini M, Hirsch E (2019) Class II PI3K functions in cell biology and disease. Trends Cell Biol 29: 339\u2013359","journal-title":"Trends Cell Biol"},{"key":"BFEMBR202051299_CR16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317\u20131329","journal-title":"N Engl J Med"},{"key":"BFEMBR202051299_CR17","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1128\/MCB.25.24.11122-11130.2005","volume":"25","author":"K Harada","year":"2005","unstructured":"Harada K, Truong AB, Cai T, Khavari PA (2005) The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation. Mol Cell Biol 25: 11122\u201311130","journal-title":"Mol Cell Biol"},{"key":"BFEMBR202051299_CR18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796\u2013808","journal-title":"Nat Med"},{"key":"BFEMBR202051299_CR19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41467-017-00785-0","volume":"8","author":"JH Kim","year":"2017","unstructured":"Kim JH, Lee C, Lee M, Wang H, Kim K, Park SJ, Yoon I, Jang J, Zhao H, Kim HK et al (2017) Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat Commun 8: 732","journal-title":"Nat Commun"},{"key":"BFEMBR202051299_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060043","volume":"112","author":"JP Konsman","year":"2007","unstructured":"Konsman JP, Drukarch B, Van Dam AM (2007) (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) 112: 1\u201325","journal-title":"Clin Sci (Lond)"},{"key":"BFEMBR202051299_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00401-018-1930-z","volume":"137","author":"KL Lambertsen","year":"2019","unstructured":"Lambertsen KL, Finsen B, Clausen BH (2019) Post-stroke inflammation-target or tool for therapy? Acta Neuropathol 137: 693\u2013714","journal-title":"Acta Neuropathol"},{"key":"BFEMBR202051299_CR22","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1242\/jcs.194746","volume":"130","author":"F Law","year":"2017","unstructured":"Law F, Seo JH, Wang Z, DeLeon JL, Bolis Y, Brown A, Zong WX, Du G, Rocheleau CE (2017) The VPS34 PI3K negatively regulates RAB-5 during endosome maturation. J Cell Sci 130: 2007\u20132017","journal-title":"J Cell Sci"},{"key":"BFEMBR202051299_CR23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.cellsig.2015.05.013","volume":"27","author":"H Li","year":"2015","unstructured":"Li H, Marshall AJ (2015) Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: a distinct branch of PI3K signaling. Cell Signal 27: 1789\u20131798","journal-title":"Cell Signal"},{"key":"BFEMBR202051299_CR24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.aaf8310","volume":"356","author":"AL Marat","year":"2017","unstructured":"Marat AL, Wallroth A, Lo WT, Muller R, Norata GD, Falasca M, Schultz C, Haucke V (2017) mTORC1 activity repression by late endosomal phosphatidylinositol 3,4-bisphosphate. Science (New York, NY) 356: 968\u2013972","journal-title":"Science (New York, NY)"},{"key":"BFEMBR202051299_CR25","doi-asserted-by":"crossref","first-page":"23277","DOI":"10.1038\/srep23277","volume":"6","author":"I Mavrommati","year":"2016","unstructured":"Mavrommati I, Cisse O, Falasca M, Maffucci T (2016) Novel roles for class II phosphoinositide 3-Kinase C2beta in signalling pathways involved in prostate cancer cell invasion. Sci Rep 6: 23277","journal-title":"Sci Rep"},{"key":"BFEMBR202051299_CR26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuroimage.2012.07.018","volume":"63","author":"A Montagne","year":"2012","unstructured":"Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud J-S, Louin G, Buisson A, Haelewyn B, Docagne F et al (2012) Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. NeuroImage 63: 760\u2013770","journal-title":"NeuroImage"},{"key":"BFEMBR202051299_CR27","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1073\/pnas.92.12.5341","volume":"92","author":"PM Moran","year":"1995","unstructured":"Moran PM, Higgins LS, Cordell B, Moser PC (1995) Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci USA 92: 5341\u20135345","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR202051299_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111698","volume":"9","author":"K Nigorikawa","year":"2014","unstructured":"Nigorikawa K, Hazeki K, Guo Y, Hazeki O (2014) Involvement of class II phosphoinositide 3-kinase alpha-isoform in antigen-induced degranulation in RBL-2H3 cells. PLoS One 9: e111698","journal-title":"PLoS One"},{"key":"BFEMBR202051299_CR29","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1161\/STROKEAHA.107.487520","volume":"38","author":"C Orset","year":"2007","unstructured":"Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 38: 2771\u20132778","journal-title":"Stroke"},{"key":"BFEMBR202051299_CR30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature12360","volume":"499","author":"Y Posor","year":"2013","unstructured":"Posor Y, Eichhorn-Gruenig M, Puchkov D, Sch\u00f6neberg J, Ullrich A, Lampe A, M\u00fcller R, Zarbakhsh S, Gulluni F, Hirsch E et al (2013) Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. Nature 499: 233\u2013237","journal-title":"Nature"},{"key":"BFEMBR202051299_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/brain\/aww260","volume":"140","author":"A Quenault","year":"2017","unstructured":"Quenault A, Martinez de Lizarrondo S, Etard O, Gauberti M, Orset C, Haelewyn B, Segal HC, Rothwell PM, Vivien D, Touz\u00e9 E et al (2017) Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack. Brain 140: 146\u2013157","journal-title":"Brain"},{"key":"BFEMBR202051299_CR32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","volume":"10","author":"RA Swanson","year":"1990","unstructured":"Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290\u2013293","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFEMBR202051299_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053808","volume":"8","author":"G Tibolla","year":"2013","unstructured":"Tibolla G, Pineiro R, Chiozzotto D, Mavrommati I, Wheeler AP, Norata GD, Catapano AL, Maffucci T, Falasca M (2013) Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. PLoS One 8: e53808","journal-title":"PLoS One"},{"key":"BFEMBR202051299_CR34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41556-019-0377-3","volume":"21","author":"A Wallroth","year":"2019","unstructured":"Wallroth A, Koch PA, Marat AL, Krause E, Haucke V (2019) Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1. Nat Cell Biol 21: 1093\u20131101","journal-title":"Nat Cell Biol"},{"key":"BFEMBR202051299_CR35","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","volume":"19","author":"Bb Weksler","year":"2005","unstructured":"Weksler Bb, Subileau Ea, Perri\u00e8re N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P et al (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872\u20131874","journal-title":"FASEB J"},{"key":"BFEMBR202051299_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","volume":"10","author":"B Weksler","year":"2013","unstructured":"Weksler B, Romero IA, Couraud PO (2013) The hCMEC\/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10: 16","journal-title":"Fluids Barriers CNS"},{"key":"BFEMBR202051299_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2824","volume":"15","author":"F Wessel","year":"2014","unstructured":"Wessel F, Winderlich M, Holm M, Frye M, Rivera-Galdos R, Vockel M, Linnepe R, Ipe U, Stadtmann A, Zarbock A et al (2014) Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol 15: 223\u2013230","journal-title":"Nat Immunol"},{"key":"BFEMBR202051299_CR38","first-page":"298","volume":"11","author":"Y Xiong","year":"2010","unstructured":"Xiong Y, Mahmood A, Chopp M (2010) Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 11: 298\u2013308","journal-title":"Curr Opin Investig Drugs"},{"key":"BFEMBR202051299_CR39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/ATVBAHA.115.306549","volume":"36","author":"Z Yan","year":"2016","unstructured":"Yan Z, Wang ZG, Segev N, Hu S, Minshall RD, Dull RO, Zhang M, Malik AB, Hu G (2016) Rab11a mediates vascular endothelial-cadherin recycling and controls endothelial barrier function. Arterioscler Thromb Vasc Biol 36: 339\u2013349","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFEMBR202051299_CR40","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dore S, Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol 316: C135\u2013C153","journal-title":"Am J Physiol"},{"key":"BFEMBR202051299_CR41","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nm.2928","volume":"18","author":"K Yoshioka","year":"2012","unstructured":"Yoshioka K, Yoshida K, Cui H, Wakayama T, Takuwa N, Okamoto Y, Du W, Qi X, Asanuma K, Sugihara K et al (2012) Endothelial PI3K-C2alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med 18: 1560\u20131569","journal-title":"Nat Med"},{"key":"BFEMBR202051299_CR42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2009.01.032","volume":"136","author":"R Zoncu","year":"2009","unstructured":"Zoncu R, Perera RM, Balkin DM, Pirruccello M, Toomre D, De Camilli P (2009) A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136: 1110\u20131121","journal-title":"Cell"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202051299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.202051299","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.202051299\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.202051299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202051299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:47:40Z","timestamp":1779112060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.202051299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,4]]}},"alternative-id":["BFEMBR202051299"],"URL":"https:\/\/doi.org\/10.15252\/embr.202051299","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.V. is a consultant for Karus Therapeutics (Oxford, UK), iOnctura (Geneva, Switzerland), and Venthera (Palo Alto, US) and has received speaking fees from Gilead. The other authors have no competing financial interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBR202051299"}}